Rockefeller Capital Management
KZIA

Rockefeller Capital Management’s Kazia Therapeutics KZIA Stock Holding History

Rockefeller Capital Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Hold
12,700
– – ﹤0.01% 2663
2026
Q1 		$94.5K Buy
12,700
+2,000
+19% +$13.9K ﹤0.01% 2909
2025
Q4 		$73.7K Hold
10,700
– – ﹤0.01% 2877
2025
Q3 		$77.1K Buy
+10,700
New +$88.8K ﹤0.01% 2707

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rockefeller Capital Management's KZIA Position: Q2 2026 in Review

Rockefeller Capital Management held its Kazia Therapeutics (KZIA) position steady in Q2 2026 at 12,700 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #2663.

Rockefeller Capital Management first reported a position in KZIA in Q3 2025 and has held it in 4 quarters since. 35 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Rockefeller Capital Management held 12,700 shares of Kazia Therapeutics worth $179K as of Q2 2026.
  • Rockefeller Capital Management left its Kazia Therapeutics share count unchanged in Q2 2026.
  • Kazia Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2663 holding.
  • Rockefeller Capital Management first reported a position in Kazia Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 35 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.